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The Tobacco Dependence Clinic: 
Gender issues and possibilities in 
Cessation Treatment 
Date: April 19th 2012 
Chizimuzo Okoli and Milan Khara 
iTAG 2012 Annual Spring Meeting 
From Kalman, Morissette and George (2005), Am. J. Addict., 14: 106-123  
Background & Significance 
iTAG 2012 Annual Spring Meeting 
Program Description 
• The Tobacco Dependence Clinic (TDC) is a program that 
provides behavioural counselling and up to 6-7months of no-
cost pharmacotherapy for clients through VCH Mental Health 
and Addiction Services 
 
• Program is run with a team of nurses, counsellors, respiratory 
therapists, and a physician. 
 
• Currently in 7 Addictions services located in community 
health centres in Vancouver. 
Eligibility:  
• 19 years or older 
• Tobacco dependent 
• Have a history of substance use disorder and/or mental illness 
• Financially disadvantaged 
8-week structured group: 
 
Phase 1: engagement in the process – weeks 1-2 
 
Phase 2: planning for change – weeks 3-4 
 
Phase 3: sustaining change – weeks 5-8 
 
 
Treatment Approach 
Program philosophy: Quitting smoking is a process and not an event 
Aims  
• To examine sex/gender differences in factors 
associated with substance use, psychiatric 
disorders, and smoking among participants of the 
TDC program  
 
• To examine predictors of program completion and 
smoking cessation among participants of the TDC 
program 
 
Sample 
1004 
Participated in Program 
 
(Sept 2007 to Dec 2010) 
326 
•80 Repeat clients  
•246 Not engaged in the program (i.e., 
had two or less contacts with the 
program) 
678* 
Intent to treat 
155 (22.9%) 
Male: 25.6% 
Female: 18.8% 
Program non-completers 
523 (77.1%) 
Male: 74.4% 
Female: 81.2% 
Program completers 
*Three individuals selected ‘other’ in response to gender and were not included in analyses 
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Substance Use Disorder & Psychiatric Disorder History 
 (N = 675) 
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Table1. Baseline Characteristics (N = 678) 
Women Men 
Mean SD Mean SD 
Age of participant (years)** 44.3 11.1 50.7 10.1 
 
Cigarettes smoked per day** 18.7 8.6 21.6 11.3 
 
Age at smoking initiation**  14.4 4.8 15.6 6.4 
 
Importance of quitting  
(scale of 0 ‘low’ to 10 ‘high’) 
9.0 1.3 9.0 1.4 
Confidence in quitting**  
(scale of 0 ‘low’ to 10 ‘high’) 
7.0 2.4 7.4 2.4 
FTND at Baseline 5.8 2.0 6.1 2.0 
 
CO level** 19.5 12.4 21.8 15.1 
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Note. **indicates significant gender differences 
Program Completion (n = 675) 
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* Statistically significant differences by gender 
* 
Smoking Cessation* Outcomes at end-of-treatment (n = 521)  
*Smoking cessation at end-of-treatment (i.e., anytime between 8 weeks to 26 weeks) 
verified by expired CO levels 
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Smoking cessation by SUD and PD among 
program completers (n = 521)* 
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Smoking Cessation by length of stay in the program (n = 675)*  
* Statistically significant differences between week categories in total sample and by gender 
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Multivariate predictorsa of program completion (n = 675b) 
a. Employing a two-step model building process in which variables associated with smoking cessation (at alpha < 1.0) 
in the unadjusted analyses are included in a second-step for adjusted analyses. Only variables which were 
significantly predictive of smoking cessation in the final adjusted multivariate model are shown.  
b. Analysis includes repeat clients to the TDC 
       *  = p <.05, ** = p <.001, *** = p <.001 
Total Sample Males Females 
Predictors Odds 
Ratio 
95% CI Odds 
Ratio 
95% CI Odds 
Ratio 
95% CI 
Gender 
Male (referent) 
Female 
 
     1.0 
1.78** 
 
- 
1.19-2.65 
-- -- -- -- 
       Age 1.03** 1.01-1.05 1.03** 1.01-1.06 -- -- 
Importance to quit - - - - 1.26* 1.01-1.56 
Multivariate predictorsa of smoking cessation among 
program completers at end of treatment (n = 494) 
a. Employing a two-step model building process in which variables associated with smoking cessation (at alpha < 1.0) 
in the unadjusted analyses are included in a second-step for adjusted analyses. Only variables which were 
significantly predictive of smoking cessation in the final adjusted multivariate model are shown.  
 
* = p <.05, ** = p <.001, *** = p <.001 
Total Sample Males Females 
Predictors Odds 
Ratio 
95% CI Odds 
Ratio 
95% CI Odds 
Ratio 
95% CI 
History of PD 
None 
(referent) 
Mood 
Anxiety 
Psychotic 
 
     1.00 
.86 
.53* 
.64 
 
- 
.55-1.36 
.28-1.00 
.28-1.45 
 
   1.00 
.68 
.41* 
.28* 
 
- 
.39-1.19 
.16-1.00 
.10-.80 
-- -- 
FTND .89* .80-.99 .88* .78-.99 -- -- 
Total Visits 1.07*** 1.03-1.10 1.08*** 1.04-1.12 1.05* 1.01-1.09 
Summary of Key Findings 
• Associations with gender: 
o Women were more likely to have a history of a mental 
illness and complete the program.  
o Men were more likely to have a substance use disorder, be 
older, smoke more cigarettes per day, and have greater 
confidence in their ability to quit 
 
• Associations with smoking cessation in stratified analysis: 
o Among men, poor smoking cessation was associated with 
having an anxiety or psychotic disorder (as compared to 
no psychiatric disorder), higher nicotine dependence at 
baseline, and less visits to the program. 
o Among women, poor smoking cessation was associated 
with less visits to the program. 
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